Results 41 to 50 of about 6,158,996 (355)
International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate : A meta-analysis of 1446 patients [PDF]
, 2007 OBJECTIVE: To review pooled phase II data to identify features of different regimens of intermittent hormone therapy (IHT), developed to reduce the morbidity of treating metastatic prostate cancer, and which carries a theoretical advantage of delaying ...
Cuzick, Jack +6 more
core +1 more source
Keratoconus progression associated with hormone replacement therapy
American Journal of Ophthalmology Case Reports, 2019 Purpose: To report a postmenopausal patient with keratoconus who experienced significant progression after using hormone replacement therapy. Observations: A 51-year-old woman with previously stable keratoconus presented with acute disease progression ...
Giulia Coco +4 more
doaj +1 more source
BMC Women's Health, 2023 Background Menopause is a specific physical and psychological transition period for women, during which they experience a series of menopausal symptoms. Menopausal hormone therapy is an important treatment for improving menopausal symptoms. Helping women
Jie Lu +7 more
doaj +1 more source
Growth hormone therapy in HHRH
Bone Reports, 2022 Background: Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) (SLC34A3 gene, OMIM 241530) is an autosomal recessive disorder that results in a loss of function of the sodium-phosphate NPT2c channel at the proximal tubule.
Guido Filler, MD, PhD +6 more
doaj +1 more source
Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women [PDF]
, 2001 The mechanisms that mediate the cardioprotective action of steroid hormones in postmenopausal women are poorly understood. To study the inter-relationship between female steroid hormones and cardiac natriuretic peptides, plasma levels of atrial ...
A. Clerico +3 more
core +1 more source
BMC Cancer, 2023 Background Non-metastatic breast cancer treatment is mainly based on surgery, with or without chemotherapy, radiotherapy and/or hormone therapy. To reduce the risk of hormone receptor positive (HR+) disease recurrence, hormone therapy is prescribed for ...
François Gernier +23 more
doaj +1 more source
The Potential Effects of Hormonal Therapy and Stress on the Oral Health of the Transitioning Population [PDF]
, 2020 Problem: In terms of healthcare, the transgender population is underserved. Unfortunately, these individuals often experience stress related to seeking preventative care and fear discrimination.
Cantwell, Elena G, McClure, Devon
core +1 more source
The Clinical Significance of Subclinical Thyroid Dysfunction. [PDF]
, 2008 Subclinical thyroid disease (SCTD) is defined as serum free T(4) and free T(3) levels within their respective reference ranges in the presence of abnormal serum TSH levels.
BIONDI, BERNADETTE, COOPER DS
core +1 more source
Current medical treatment of estrogen receptor-positive breast cancer [PDF]
, 2015 Approximately 80% of breast cancers (BC) are estrogen receptor (ER)-positive and thus endocrine therapy (ET) should be considered complementary to surgery in the majority of patients.
Basso, S. M. M. +2 more
core +1 more source
Which patients with prostate cancer are actually candidates for hormone therapy?
International Brazilian Journal of Urology, 2004 In this article, we will try to address the following aspects: which factors are responsible of the introduction of new candidates for hormone therapy in prostate cancer, who are actually candidates for hormone therapy, classifying them on the basis of ...
Alessandro Sciarra +5 more
doaj +1 more source